The periurethral glands do not significantly influence the serum prostate specific antigen concentration

Journal of Urology

Volumn 155, Issue 5, 1996, Pages 1658-1660

  Oesterling, Joseph E ^a   Tekchandani, Anita H ^b   Martin, Sandra K ^b   Bergstralh, Erik J ^b   Reichstein, Esther ^b   Diamandis, Eleftherios P ^b   Yemoto, Cheryl ^b   Stamey, Thomas A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

bladder neoplasms; prostate specific antigen; prostatic neoplasms; urethra

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CYSTECTOMY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATECTOMY; TRANSITIONAL CELL CARCINOMA; URETHRA SURGERY;

EID: 0030008241     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66156-1     Document Type: Article

References (11)

1. Iwakiri, J., Grandbois, K., Wehner, N., Graves, H. C. B. and Stamey, T.: An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J. Urol., 149: 783, 1993.
2. Kamoshida, S. and Tsutsumi, Y.: Extraprostatic localization of prostatic acid phosphatase and prostate specific antigen: distribution in cloacogenic glandular epithelium and sex dependent expression in human anal gland. Hum. Path., 21: 1108, 1990.
3. Frazier, H. A., Humphrey, P. A., Burchette, J. L. and Paulson, D. F.: Immunoreactive prostatic specific antigen in male periurethral glands. J. Urol., 147: 246, 1992.
4. Prestigiacomo, A. F. and Stamey, T. A.: A comparison of 4 ultra-sensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J. Urol., 152: 1515, 1994.
5. Newman, E. S., Reichstein, E., El-Shami, S. and Lei, J. D.: A high sensitivity chemiluminescent immunoassay for prostatic specific antigen. Clin. Chem., 40: 162, 1994.
6. Yu, H. and Diamandis, E. P.: Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin. Chem., 39: 2108, 1993.
7. Partin, A. W. and Oesterling, J. E.: The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358, 1994.
8. Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer., 20: 713, 1993.
9. Montie, J. E.: Follow-up after radical prostatectomy or radiation therapy for prostate cancer. Urol. Clin. N. Amer., 21: 673, 1994.
10. Takayama, T. K., Vessella, R. L. and Lange, P. H.: Abrief review of ultrasensitive prostate-specific antigen assays for the evaluation of patients after radical prostatectomy. World J. Urol., 11: 192, 1993.
11. Takayama, T. K., Vessella, R. L., Brawer, M. K., Noteboom, J. and Lange, P. H.: The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J. Urol., 150: 374, 1993.